Suzuki, Masataka http://orcid.org/0000-0001-5352-8595
Shimizu-Hirota, Ryoko
Mita, Masashi
Hamase, Kenji
Sasabe, Jumpei http://orcid.org/0000-0002-5093-2987
Funding for this research was provided by:
Shiseido Group
School of Medicine, Keio University
Article History
Received: 29 November 2021
Accepted: 10 February 2022
First Online: 28 February 2022
Declarations
:
: The authors have no relevant financial interests to disclose.
: MM is founder and CEO of KAGAMI INC., a startup company working on chiral amino acids analysis and research for medical application.
: This study was approved by the institutional Ethics Committee and conducted in accordance with the Helsinki Declaration and institutional guidelines for clinical studies at Keio University Hospital (Approval number: 20150165). We obtained consent from 93 of 104 individuals, who had received a colonoscopy or a comprehensive health examination in the Center of Preventive Medicine at Keio University Hospital from March to May, 2016.
: Not applicable.
: Not applicable.